<?xml version="1.0" encoding="UTF-8"?>
<results title="tropicalVirus">
 <result pre="PathogensPathogenspathogensPathogens2076-0817MDPI pmcid: 6963678 doi: 10.3390/pathogens8040193pathogens-08-00193 : Review Current Understanding of" exact="West Nile" post="Virus Clinical Manifestations, Immune Responses, Neuroinvasion, and Immunotherapeutic Implications"/>
 <result pre="of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract" exact="West Nile" post="virus (WNV) is the most common mosquito-borne virus in"/>
 <result pre="ages, although elderly and immunocompromised individuals are particularly at risk." exact="WNV" post="neuroinvasive disease has killed over 2300 Americans since WNV"/>
 <result pre="risk. WNV neuroinvasive disease has killed over 2300 Americans since" exact="WNV" post="entered into the United States in the New York"/>
 <result pre="progress has been made in both understanding the pathogenesis of" exact="WNV" post="and treatment in clinical practices. This review summarizes our"/>
 <result pre="in clinical practices. This review summarizes our current understanding of" exact="WNV" post="infection in terms of human clinical manifestations, host immune"/>
 <result pre="human clinical manifestations, host immune responses, neuroinvasion, and therapeutic interventions." exact="West Nile" post="virus immune response neuroinvasion clinical manifestation therapeutic implication 1."/>
 <result pre="immune response neuroinvasion clinical manifestation therapeutic implication 1. Introduction to" exact="West Nile" post="virus West Nile virus (WNV) belongs to the flavivirus"/>
 <result pre="clinical manifestation therapeutic implication 1. Introduction to West Nile virus" exact="West Nile" post="virus (WNV) belongs to the flavivirus genus in the"/>
 <result pre="the endosome into the cytoplasm after acidification-induced membrane fusion [1,2,3]." exact="WNV" post="has an approximately 11 kb long, single-stranded, positive sensed"/>
 <result pre="the prM, resulting in the release of mature virion [8]." exact="WNV" post="is cytolytic and induces apoptosis in a variety of"/>
 <result pre="hosts including humans, horses, and birds. In humans, infections with" exact="WNV" post="are either asymptomatic or can lead to life-threatening neuroinvasive"/>
 <result pre="remains the standard. Here, we review the current understanding of" exact="WNV" post="epidemiology, clinical manifestations, protective immune responses, mechanisms of neuroinvasion"/>
 <result pre="mechanisms of neuroinvasion and neuropathogenesis, and provide immunotherapeutic implications. 2." exact="WNV" post="Epidemiology In nature, WNV transmission is maintained in a"/>
 <result pre="neuropathogenesis, and provide immunotherapeutic implications. 2. WNV Epidemiology In nature," exact="WNV" post="transmission is maintained in a cycle between Culex mosquitoes,"/>
 <result pre="Humans, horses, and other vertebrate animals can be infected with" exact="WNV" post="through the bite of an infected mosquito, but are"/>
 <result pre="Disease Control and Prevention (CDC), most people (80%) infected with" exact="WNV" post="do not develop any symptoms, and about 20% infected"/>
 <result pre="rash. About 1 in 150 people who are infected with" exact="WNV" post="develop a severe illness affecting the central nervous system"/>
 <result pre="the Romania epidemic in 1996 marked the geographic transition of" exact="WNV" post="epidemics from rural areas to urban industrialized areas [11]."/>
 <result pre="from rural areas to urban industrialized areas [11]. In 1999," exact="WNV" post="gained entry into North America in New York City"/>
 <result pre="the neighboring countries in North America [13]. Phylogenetic analysis of" exact="WNV" post="isolated from the U.S. indicates that a single conserved"/>
 <result pre="since 2002, but is also found in old-world strains of" exact="WNV" post="[14]. This genotype has effectively displaced the genotype originally"/>
 <result pre="effectively displaced the genotype originally introduced to the U.S. [14]." exact="WNV" post="has now spread across six of seven continents, including"/>
 <result pre="important causative agents of human viral encephalitis worldwide. Since 1999," exact="WNV" post="has been estimated to cause more than 6 million"/>
 <result pre="is an urgent need to understand in-depth the pathogenesis of" exact="WNV" post="and develop specific treatment strategies. 3. Clinical Manifestations of"/>
 <result pre="WNV and develop specific treatment strategies. 3. Clinical Manifestations of" exact="WNV" post="Infection WNV fever and neuroinvasive disease: WNV infection in"/>
 <result pre="develop specific treatment strategies. 3. Clinical Manifestations of WNV Infection" exact="WNV" post="fever and neuroinvasive disease: WNV infection in humans can"/>
 <result pre="Clinical Manifestations of WNV Infection WNV fever and neuroinvasive disease:" exact="WNV" post="infection in humans can result in a spectrum of"/>
 <result pre="ranging from a febrile illness classified by the CDC as" exact="WNV" post="fever to severe neuroinvasive disease classified as meningitis, encephalitis,"/>
 <result pre="encephalitis, or acute flaccid paralysis (poliomyelitis variant) [16]. Before 1996," exact="WNV" post="was primarily known to cause febrile illness, now classified"/>
 <result pre="to cause febrile illness, now classified by the CDC as" exact="WNV" post="fever and often described as a &quot;summer flu�? associated"/>
 <result pre="rash. By definition, neurological symptoms (neuroinvasion) do not occur in" exact="WNV" post="fever patients and most recover completely, but fatigue and"/>
 <result pre="2002, approximately half of reported cases have been classified as" exact="WNV" post="fever and half as neuroinvasive disease. For example, in"/>
 <result pre="fever and half as neuroinvasive disease. For example, in the" exact="WNV" post="epidemic of 2012, of the 5387 reported WNV cases"/>
 <result pre="in the WNV epidemic of 2012, of the 5387 reported" exact="WNV" post="cases nationwide, 2734 (51%) were classified as neuroinvasive disease"/>
 <result pre="symptoms, including encephalitis, meningitis or acute flaccid paralysis [16]. Moreover," exact="WNV" post="infection has also been indicated to cause longitudinally extensive"/>
 <result pre="much more frequently, together with neuromuscular manifestations. Neuromuscular manifestations and" exact="WNV" post="poliomyelitis: In the 1999 New York City outbreak, more"/>
 <result pre="York City outbreak, more than 50% of patients with confirmed" exact="WNV" post="encephalitis had severe muscle weakness as a cardinal sign"/>
 <result pre="or severe axonal polyneuropathy [12,20,21]. In the 2002 and 2003" exact="WNV" post="epidemics, neuromuscular manifestations were a well-recognized feature associated with"/>
 <result pre="are now recognized as a prominent feature in patients with" exact="WNV" post="neuroinvasive disease [25]. Most physicians who are actively involved"/>
 <result pre="neuroinvasive disease [25]. Most physicians who are actively involved in" exact="WNV" post="clinical research now accept a poliomyelitis to be the"/>
 <result pre="most common cause of WNV-associated acute flaccid paralysis. Patients with" exact="WNV" post="poliomyelitis commonly have associated signs of meningitis, encephalitis, or"/>
 <result pre="on electrodiagnostic testing that occasionally are reported in patients with" exact="WNV" post="infection [24]. However, sensory loss attributed to WNV has"/>
 <result pre="patients with WNV infection [24]. However, sensory loss attributed to" exact="WNV" post="has not been a prominent clinical finding. WNV infection"/>
 <result pre="attributed to WNV has not been a prominent clinical finding." exact="WNV" post="infection and autonomic nervous system: To date, there are"/>
 <result pre="that dysautonomia plays in the morbidity and mortality of human" exact="WNV" post="infection. Yet, symptoms of dysautonomia are commonly observed during"/>
 <result pre="Yet, symptoms of dysautonomia are commonly observed during the acute" exact="WNV" post="infection and in WNV survivors recovered from the acute"/>
 <result pre="are commonly observed during the acute WNV infection and in" exact="WNV" post="survivors recovered from the acute illness. In one study"/>
 <result pre="recovered from the acute illness. In one study of 44" exact="WNV" post="patients that reported prolonged (&amp;gt; 6 months) post-infectious symptoms,"/>
 <result pre="in 9 (20%) [30]. In our initial series of 54" exact="WNV" post="patients from 2002 to 2006 who had extensive electrodiagnostic"/>
 <result pre="have also been observed by other clinicians [31,32]. In rodents," exact="WNV" post="can lead to autonomic dysfunction by infecting neurons controlling"/>
 <result pre="neurons in the brainstem were identified to be infected with" exact="WNV" post="[33]. The authors concluded that that infected neurons controlling"/>
 <result pre="identified in the sinoatrial (SA) and atrioventricular (AV) nodes [33]." exact="WNV" post="infection of hamsters has also been reported to cause"/>
 <result pre="changes in sweating, have also been observed in patients with" exact="WNV" post="infection [36]. Hence, both human and animal data suggest"/>
 <result pre="infection [36]. Hence, both human and animal data suggest that" exact="WNV" post="can cause dysautonomia, supporting the concept that the neurotropism"/>
 <result pre="can cause dysautonomia, supporting the concept that the neurotropism of" exact="WNV" post="may extend to autonomic neurons in the CNS and"/>
 <result pre="the CNS and autonomic ganglia. 4. Protective Immune Responses to" exact="WNV" post="Infection 4.1. Innate Immunity The innate immune system serves"/>
 <result pre="trigger the production of interferon I (FN) and other cytokines." exact="WNV" post="has an ssRNA genome but makes dsRNA intermediates while"/>
 <result pre="signaling of TLR3 in mice has been shown to facilitate" exact="WNV" post="infection by increasing the permeability of the blood-brain-barrier (BBB),"/>
 <result pre="while another report suggested that TLR3 might protect mice from" exact="WNV" post="infection [38,39,40]. Our research has demonstrated that TLR7 signaling"/>
 <result pre="has demonstrated that TLR7 signaling plays a protective role against" exact="WNV" post="infection in mouse models by triggering IL-23 mediated immune"/>
 <result pre="TLR8 in mice [42]. Although TLR8 may not directly sense" exact="WNV" post="RNA, it interacts with suppressor of cytokine signaling (SOCS)-1"/>
 <result pre="to confer CD8+ T cell-number expansion and effector functions against" exact="WNV" post="and other RNA viruses [53]. Mammalian cell PRRs recognize"/>
 <result pre="RNA viruses [53]. Mammalian cell PRRs recognize the PAMPs of" exact="WNV" post="and induce type I IFN productions during the early"/>
 <result pre="induce type I IFN productions during the early stages of" exact="WNV" post="infection. Experimental mice with genetic defects in the receptor"/>
 <result pre="tissues, leading to rapid lethality [54]. The induced IFN restricts" exact="WNV" post="viral replication, however, WNV has evolved to counter IFN"/>
 <result pre="lethality [54]. The induced IFN restricts WNV viral replication, however," exact="WNV" post="has evolved to counter IFN function at multiple steps"/>
 <result pre="inhibit type I IFN production or signaling [55,60,61,62,63]. In addition," exact="WNV" post="is resistant to the antiviral effects of IFN in"/>
 <result pre="has been observed in animal models or humans infected with" exact="WNV" post="[64]. Dendritic cell and macrophage: Mosquito transmitted WNV infection"/>
 <result pre="infected with WNV [64]. Dendritic cell and macrophage: Mosquito transmitted" exact="WNV" post="infection begins in the skin, and the virus replicates"/>
 <result pre="skin resident dendritic cells (DCs). After being activated by the" exact="WNV" post="antigens, LCs can migrate to the draining lymph node,"/>
 <result pre="leading to T-cell priming. In a murine model of dermal" exact="WNV" post="infection, bone marrow-derived monocytes infiltrate the skin, cluster near"/>
 <result pre="has been shown that human monocyte-derived DCs are permissive to" exact="WNV" post="infection, and secret high levels of type I IFN"/>
 <result pre="infected with WNV, which could partially explain the more severe" exact="WNV" post="infections in elderly patients [67]. However, type I IFN"/>
 <result pre="immunity in AXL receptor tyrosine kinase deficient (Axl−/−) mice during" exact="WNV" post="and influenza infection [70]. Recent studies showed that IL-1β,"/>
 <result pre="7 are important to induce DC-mediated antivirus IFN responses against" exact="WNV" post="infection [71,72,73]. Besides DCs, macrophages as specialized phagocytes and"/>
 <result pre="phagocytes and antigen-presenting cells are early responders to control initial" exact="WNV" post="replication and present the viral antigens to T cells."/>
 <result pre="present the viral antigens to T cells. Macrophages efficiently ingest" exact="WNV" post="through receptor-mediated endocytosis, then become activated to produce a"/>
 <result pre="I IFNs. These molecules are critical for the restriction of" exact="WNV" post="replication and the recruitment of more innate immune cells"/>
 <result pre="of infection [41]. The role of macrophages in resistance to" exact="WNV" post="infection has been shown in mice depleted of macrophages,"/>
 <result pre="of the CNS, become activated and produce proinflammatory molecules upon" exact="WNV" post="infection [40,41]. Recently, it has been shown that defective"/>
 <result pre="WNV infection [40,41]. Recently, it has been shown that defective" exact="WNV" post="replication in Peli1 (an E3 ubiquitin ligase)-deficient microglia and"/>
 <result pre="the pathogenesis of WNV. Neutrophils can serve as reservoirs for" exact="WNV" post="replication and dissemination in the early stages of infection"/>
 <result pre="dissemination in the early stages of infection but contribute to" exact="WNV" post="clearance later in the infection process [77]. In addition,"/>
 <result pre="[77]. In addition, neutrophils have also been documented to facilitate" exact="WNV" post="neuroinvasion via &quot;Trojan horse�? transport [78,79]. Natural Killer (NK)"/>
 <result pre="[80]. However, the reported roles of NK cells in controlling" exact="WNV" post="infection in mice are complex. Although NK cells can"/>
 <result pre="cells can be activated and recruited in the CNS following" exact="WNV" post="infection in mice, and they have been shown to"/>
 <result pre="strain of mice also failed to alter the susceptibility to" exact="WNV" post="infection, suggesting NK cells may not have a primary"/>
 <result pre="NK cells may not have a primary role in controlling" exact="WNV" post="infection and disease in mice [82]. In contrast, human"/>
 <result pre="human NK cells can be activated and able to inhibit" exact="WNV" post="infection of Vero cells through both cytolytic and noncytolytic"/>
 <result pre="cells have been shown to mount a robust response to" exact="WNV" post="infection, resulting in cytolytic activity, cytokine secretion, and chemokine"/>
 <result pre="lack of NK protection in mice may be due to" exact="WNV" post="suppressing or bypassing the NK response. Therefore, it is"/>
 <result pre="The detailed roles of NK cells in the pathogenesis of" exact="WNV" post="need to be further investigated. Gamma-Delta T cell: γδ"/>
 <result pre="pathogenic roles of γδ T cells have been indicated during" exact="WNV" post="infection. In mouse models, both γδ T cell-deficient (TCRδ−/−)"/>
 <result pre="been suggested to contribute to regulate intracellular perforin levels against" exact="WNV" post="in the periphery αβ T cells [86]. In contrast,"/>
 <result pre="peripheral γδ T cells have been implied to contribute to" exact="WNV" post="pathogenesis in mice. Depletion of Vγ4+ cells in mice"/>
 <result pre="in lower levels of viremia, encephalitis, and mortality rates following" exact="WNV" post="infection. The pathogenic effects of Vγ4+ cells are mediated"/>
 <result pre="shown to compromise the integrity of the BBB and facilitate" exact="WNV" post="entry into the brain [40]. Anti-inflammatory cytokine IL-10 has"/>
 <result pre="has been shown to play a negative role in controlling" exact="WNV" post="infection in mice [88]. Vγ4+ cell-depleted mice had reduced"/>
 <result pre="load in the brain and a lower mortality rate to" exact="WNV" post="encephalitis [89]. In addition, Vγ4+ cells negatively regulate Vγ1+"/>
 <result pre="Vγ1+ T cell responses via the production of TGF-β during" exact="WNV" post="infection [89]. 4.2. Complement The complement system consists of"/>
 <result pre="C3. The complement system has a protective role in controlling" exact="WNV" post="infection. WNV infection in mice deficient in complement receptor"/>
 <result pre="complement system has a protective role in controlling WNV infection." exact="WNV" post="infection in mice deficient in complement receptor 1 (CR1)"/>
 <result pre="factor D all resulted in increased mortality in mice following" exact="WNV" post="infection. Furthermore, the lack of complement functions might also"/>
 <result pre="in the deficiency of B and T cell responses to" exact="WNV" post="[91]. MBL recognizes N-linked glycans on the structural proteins"/>
 <result pre="[91]. MBL recognizes N-linked glycans on the structural proteins of" exact="WNV" post="and DENV, resulting in neutralization through a C3- and"/>
 <result pre="canonical and bypass lectin activation pathways [92]. Soluble and cell-surface-associated" exact="WNV" post="NS1 has been shown to bind to and recruit"/>
 <result pre="The complement component C1q increases the potency of antibodies against" exact="WNV" post="by modulating the stoichiometric requirements for neutralization [96]. However,"/>
 <result pre="in MBL-A and MBL-C or MASP-2 were more vulnerable to" exact="WNV" post="infection than WT mice, they had comparable kinetics of"/>
 <result pre="pathway might have important yet subordinate functions in protecting against" exact="WNV" post="infection [97]. In addition, using C5-depleted or -deficient human"/>
 <result pre="suggested that C5 might not either contribute to protection against" exact="WNV" post="pathogenesis or augment the neutralizing efficacy of complement-fixing anti-WNV"/>
 <result pre="Antibody and B cells are essential in the defense against" exact="WNV" post="infection in that mice deficient in B cells and"/>
 <result pre="WT, μMT and RAG1 (T and B cell-deficient) mice from" exact="WNV" post="infection. Antibody by itself did not eliminate viral reservoirs"/>
 <result pre="IgM and secreting other antibody isotypes, are vulnerable to lethal" exact="WNV" post="infection [101]. These results demonstrated that the early anti-WNV"/>
 <result pre="demonstrated that the early anti-WNV IgM in the course of" exact="WNV" post="infection limits viremia and dissemination into the CNS. The"/>
 <result pre="this, mice deficient in interferon-induced transmembrane protein, Ifitm3, infected with" exact="WNV" post="showed decreases in the total number of B cells,"/>
 <result pre="mice deficient in interferon regulatory factor 5 (Irf5−/−) infected with" exact="WNV" post="exhibited small differences in the type I IFN response"/>
 <result pre="these mice [105]. Furthermore, B cell and humoral responses to" exact="WNV" post="infection have been suggested to be regulated by many"/>
 <result pre="and TNF-α). CD8+ T cells are essential in protecting from" exact="WNV" post="infection. Early studies using rag-deficient mice that lack all"/>
 <result pre="MHC class Ia-deficient mice demonstrated a protective role in clearing" exact="WNV" post="infection in the CNS and peripheral tissues [100,111]. In"/>
 <result pre="infection in the CNS and peripheral tissues [100,111]. In addition," exact="WNV" post="infection of mice deficient in perforin, fas ligand and"/>
 <result pre="been shown to increase the survival of the mice from" exact="WNV" post="infection [118]. Collectively, the results from these studies indicated"/>
 <result pre="CD8+ T cells play an important protective role in controlling" exact="WNV" post="infection. However, studies also showed a potential pathogenic role"/>
 <result pre="showed a potential pathogenic role for CD8+ T cells in" exact="WNV" post="infection. High doses (108 PFU) of Sarafend strain of"/>
 <result pre="WNV infection. High doses (108 PFU) of Sarafend strain of" exact="WNV" post="infection in CD8−/− mice lead to the increased survival,"/>
 <result pre="T cells are involved in both recovery and immunopathology in" exact="WNV" post="infection [119]. Additionally, when mice lacking the interferon-stimulated gene"/>
 <result pre="survived better than the isotype control mice following a mutant" exact="WNV" post="(E218A) infection, in which NS5 lacks 2′-O methyltransferase activity,"/>
 <result pre="Therefore, while CD8 T cells are required for control of" exact="WNV" post="infection, they may also contribute to immunopathogenesis in some"/>
 <result pre="to have both indirect and direct roles in defense against" exact="WNV" post="infection. Infection of mice that lack CD4+ T cells"/>
 <result pre="T cells and MHC class II resulted in a prolonged" exact="WNV" post="infection in the CNS that culminated in uniform lethality"/>
 <result pre="an indirect protective role of CD4+ T cell during primary" exact="WNV" post="infection by sustaining antibody production and effector CD8+ T"/>
 <result pre="T cells may also play a direct role in limiting" exact="WNV" post="replication by producing IFN-γ, IL-2 and granzyme B, and"/>
 <result pre="that Tregs appeared to play a protective role in limiting" exact="WNV" post="disease. Tregs expanded significantly in the peripheral after WNV"/>
 <result pre="limiting WNV disease. Tregs expanded significantly in the peripheral after" exact="WNV" post="infection in both humans and mice. In humans, the"/>
 <result pre="with asymptomatic mice after infection and Treg-deficient mice developed lethal" exact="WNV" post="infection at a higher rate than the controls [124]."/>
 <result pre="RIG-I, was dispensable for Treg proliferation and suppressive capacity during" exact="WNV" post="infection in mice [126,127]. 5. WNV Neuroinvasion and Neuropathogenesis"/>
 <result pre="and suppressive capacity during WNV infection in mice [126,127]. 5." exact="WNV" post="Neuroinvasion and Neuropathogenesis Neuroinvasion: WNV can enter the CNS"/>
 <result pre="infection in mice [126,127]. 5. WNV Neuroinvasion and Neuropathogenesis Neuroinvasion:" exact="WNV" post="can enter the CNS and cause neuroinvasive diseases with"/>
 <result pre="[128,129]. Although the detailed mechanisms are still not well understood," exact="WNV" post="has been suggested to enter the CNS through multiple"/>
 <result pre="microvasculature, infection of olfactory neurons, infected leukocytes that &quot;Trojan horse�?" exact="WNV" post="to the CNS, and/or direct axonal retrograde transport from"/>
 <result pre="axonal retrograde transport from infected peripheral nerves [87,91,92,93,94,95,96,97] (Figure 1)." exact="WNV" post="replication in the peripheral organs and the blood cells,"/>
 <result pre="blood circulation that may lead to infection in the CNS." exact="WNV" post="infection in the CNS can result in meningitis, encephalitis,"/>
 <result pre="can result in meningitis, encephalitis, and acute flaccid paralysis, including" exact="WNV" post="poliomyelitis. The possible mechanisms by which WNV enters the"/>
 <result pre="flaccid paralysis, including WNV poliomyelitis. The possible mechanisms by which" exact="WNV" post="enters the CNS include: ① WNV infection induces the"/>
 <result pre="possible mechanisms by which WNV enters the CNS include: ①" exact="WNV" post="infection induces the expression of TNF-α, MIF, MMP9, ICAM-1"/>
 <result pre="BBB allowing the virus to penetrate to the CNS; ②" exact="WNV" post="may infect endothelial cells in the cerebral microvasculature, from"/>
 <result pre="which progeny viruses may be released into the CNS; ③" exact="WNV" post="may enter the CNS from infected olfactory bulbs via"/>
 <result pre="leukocytes, such as neutrophils via a &quot;Trojan horse�? transport of" exact="WNV" post="to the CNS; and ⑤ WNV may be transported"/>
 <result pre="&quot;Trojan horse�? transport of WNV to the CNS; and ⑤" exact="WNV" post="may be transported to the CNS through the infected"/>
 <result pre="the CNS through the infected peripheral nerves. In the CNS," exact="WNV" post="may infect neurons, microglia, and astrocytes producing cytokines and"/>
 <result pre="persistently elevated in the blood for months after clearance of" exact="WNV" post="from the body, which can lead to a post-infectious"/>
 <result pre="causing inflammation and neuronal death in the CNS. In mice," exact="WNV" post="induces systemic infection and then crosses the BBB, leading"/>
 <result pre="factor (MIF) are vital for the transient BBB permeabilization upon" exact="WNV" post="infection [40,131,132,133]. In addition, a study on Venezuelan equine"/>
 <result pre="to enter the brain [134]. While the initial site of" exact="WNV" post="entry into the CNS is still debatable, the rostral-caudal"/>
 <result pre="into the CNS is still debatable, the rostral-caudal spread of" exact="WNV" post="antigen from the olfactory bulb to the remaining structures"/>
 <result pre="notion because olfactory bulbs have been observed to have more" exact="WNV" post="antigens than other brain regions by immunostaining in the"/>
 <result pre="infection [41,88,137], suggesting olfactory bulbs are a possible route of" exact="WNV" post="entry into the CNS bypassing the BBB. In contrast,"/>
 <result pre="WNV entry into the CNS bypassing the BBB. In contrast," exact="WNV" post="antigen localizing to the olfactory lobes in horses and"/>
 <result pre="infected T cells and macrophages have been suggested carriers of" exact="WNV" post="into the CNS [141,142,143], however, our results demonstrated that"/>
 <result pre="WNV into the CNS [141,142,143], however, our results demonstrated that" exact="WNV" post="replicates more efficiently in human and mouse polymorphonuclear neutrophils"/>
 <result pre="are recruited into the brain at an early stage of" exact="WNV" post="infection [144]. In addition, clinical data also showed that"/>
 <result pre="into the CNS of patients at the early stage of" exact="WNV" post="neuroinvasive disease [145,146]. Our recent results show that WNV-infected"/>
 <result pre="neutrophils could play a major &quot;Trojan horse�? role in transporting" exact="WNV" post="into the CNS [78]. However, it is possible that"/>
 <result pre="neurons through the activation of mitochondrial/caspase-9 and caspase-3 pathways during" exact="WNV" post="infection [82,113,147]. In WNV-infected mice, apoptotic neurons are prominent"/>
 <result pre="but rare in the brain, suggesting that the mechanisms of" exact="WNV" post="induced cell death may differ within specific regions of"/>
 <result pre="within specific regions of the CNS [128]. In the CNS," exact="WNV" post="infects neurons, basal ganglia, brainstem and spinal cord [140],"/>
 <result pre="ganglia, brainstem and spinal cord [140], while in cell culture" exact="WNV" post="infects both neurons and astrocytes, although with differing kinetics"/>
 <result pre="courses [153]. Examination of sera and cerebrospinal fluid (CSF) from" exact="WNV" post="patients who had symptoms between 2–18 days showed elevated"/>
 <result pre="products (RAGE) could also be activated by HMGB1 released from" exact="WNV" post="infected cells undergoing necrotic cell death [157,158]. The spinal"/>
 <result pre="and showed an overall increase in S100B immunoreactivity in the" exact="WNV" post="compared to the control specimens, which may lead to"/>
 <result pre="RAGE mediated damage at other unaffected regions [156]. In addition," exact="WNV" post="infection could result in a focal loss of ganglionic"/>
 <result pre="may be severe enough to produce sensory deficits in some" exact="WNV" post="patients [29]. Post-infectious CNS symptoms: Human acute WNV infection"/>
 <result pre="in some WNV patients [29]. Post-infectious CNS symptoms: Human acute" exact="WNV" post="infection induces a significant upregulation of various proinflammatory proteins"/>
 <result pre="post-infectious proinflammatory state that may contribute to long-term neuroinflammation in" exact="WNV" post="survivors [30,78,118]. Among a large cohort of participants with"/>
 <result pre="Among a large cohort of participants with a history of" exact="WNV" post="infection in Houston, TX, USA, approximately 40% of those"/>
 <result pre="3/11) and meningitis (36%, 5/14) cases during 1–3 years following" exact="WNV" post="infection. At the second assessment between 8–11 years post-infection,"/>
 <result pre="the second assessment between 8–11 years post-infection, 57% (4/7) of" exact="West Nile" post="fever, 33% (2/6) of West Nile meningitis, and 36%"/>
 <result pre="post-infection, 57% (4/7) of West Nile fever, 33% (2/6) of" exact="West Nile" post="meningitis, and 36% (5/14) of West Nile encephalitis had"/>
 <result pre="33% (2/6) of West Nile meningitis, and 36% (5/14) of" exact="West Nile" post="encephalitis had developed new neurological complications [163]. Importantly, MRI"/>
 <result pre="MRI findings provide valuable evidence regarding the neurologic outcomes following" exact="WNV" post="CNS infection. Post-infectious CNS symptoms included post-exertion fatigue, dizziness,"/>
 <result pre="depression, anxiety, sleep disruption, and recurrent headaches [30]. Moreover, numerous" exact="WNV" post="patients have developed autoinflammatory or autoimmune-related diseases, including myasthenia"/>
 <result pre="or autoimmune-related diseases, including myasthenia gravis (MG) [165,166], suggesting that" exact="WNV" post="infection may promote or amplify underlying autoimmunity. Interestingly, RAGE"/>
 <result pre="MG [170]. These results indicate that over-expression of IL-17 following" exact="WNV" post="infection could contribute to the development of MG, although"/>
 <result pre="development of MG, although it can be beneficial in clearing" exact="WNV" post="by promoting CD8+ T cell cytotoxicity [118]. Furthermore, WNV"/>
 <result pre="clearing WNV by promoting CD8+ T cell cytotoxicity [118]. Furthermore," exact="WNV" post="infection has also been suggested to induce other autoimmune"/>
 <result pre="evidence are still needed to establish the cause-effective relationship of" exact="WNV" post="infection with autoimmune diseases. 6. Immunotherapeutic Intervention Despite the"/>
 <result pre="6. Immunotherapeutic Intervention Despite the development of four licensed veterinary" exact="WNV" post="vaccines, there are still no approved vaccines or antivirals"/>
 <result pre="difficulties in clinical study design (due to lack of enough" exact="WNV" post="cases for a phase III vaccine efficacy study), and"/>
 <result pre="high dose steroids may result in marked clinical improvement in" exact="WNV" post="patients who suffer severe neuroinflammation. Both experimental and clinical"/>
 <result pre="suggest that pro-inflammatory mediators may contribute to the pathogenesis of" exact="WNV" post="in the CNS. Treatment of infected neuronal cells with"/>
 <result pre="However, an in-depth understanding of the immune-mediated post-infectious pathogenesis of" exact="WNV" post="infection has direct therapeutic implications and treatment strategies that"/>
 <result pre="has been documented to improve the outcomes of patients with" exact="WNV" post="neuroinvasive disease. In 14 patients with acute WNV meningoencephalitis,"/>
 <result pre="patients with WNV neuroinvasive disease. In 14 patients with acute" exact="WNV" post="meningoencephalitis, intravenous dexamethasone injection was suggested to play a"/>
 <result pre="play a critical role in shortening the acute phase of" exact="WNV" post="disease and hastening patient recovery [176]. In addition, high-dose"/>
 <result pre="effect’ of high dose corticosteroids in a semi-comatose woman with" exact="WNV" post="encephalitis highlights the success of this therapeutic approach [178]."/>
 <result pre="approach [178]. Although the use of steroids in patients with" exact="WNV" post="neuroinvasive disease seems counterintuitive, with concern that immunosuppressive effects"/>
 <result pre="promote viremia and worsen outcome, the evidence is compelling that" exact="WNV" post="is rapidly cleared by immune responses in immunocompetent patients"/>
 <result pre="steroids and possibly other immunosuppressive drugs in the treatment of" exact="WNV" post="infection. The clinical experience warrants appropriate large-scale clinical trials"/>
 <result pre="of corticosteroids and other immunosuppressive drugs in the treatment of" exact="WNV" post="disease. This is particularly pertinent in light of the"/>
 <result pre="has been no successful development or marketing of a human" exact="WNV" post="vaccine. 7. Concluding Remarks WNV has become a major"/>
 <result pre="or marketing of a human WNV vaccine. 7. Concluding Remarks" exact="WNV" post="has become a major global health concern in the"/>
 <result pre="Basic and clinical research has made great progress in understanding" exact="WNV" post="biology, transmission, host immune responses, neuroinvasion, and immunopathogenesis. However,"/>
 <result pre="still be directed at further understanding of the pathogenesis of" exact="WNV" post="infection, both in animal models and humans, that will"/>
 <result pre="under Award Number R15AI135893 to F.B. P.J.S.V. was supported by" exact="West Nile" post="Research Fund administered by The Wilson Research Foundation, Jackson,"/>
 <result pre="Genet.2018959510.3389/fgene.2018.0059530564270 6.EFirthA.AtkinsJ.F.A conserved predicted pseudoknot in the NS2A-encoding sequence of" exact="West Nile" post="and Japanese encephalitis flaviviruses suggests NS1’ may derive from"/>
 <result pre="derive from ribosomal frameshiftingVirol. J.200961410.1186/1743-422X-6-1419196463 7.YoungL.B.MelianE.B.SetohY.X.YoungP.R.KhromykhA.A.Last 20 aa of the" exact="West Nile" post="virus NS1′ protein are responsible for its retention in"/>
 <result pre="Microbiol. Rev.20122563564810.1128/CMR.00045-1223034323 9.SpiglandI.Jasinska-KlingbergW.HofshiE.GoldblumN.Clinical and laboratory observations in an outbreak of" exact="West Nile" post="fever in Israel in 1957Harefuah19585427528013562703 10.WeinbergerM.PitlikS.D.GandacuD.LangR.NassarF.Ben DavidD.RubinsteinE.IzthakiA.MishalJ.KitzesR.et al.West Nile"/>
 <result pre="Dis.2001768669110.3201/eid0704.01741611585533 11.CampbellG.L.MarfinA.A.LanciottiR.S.GublerD.J.West Nile virusLancet Infect. Dis.2002251952910.1016/S1473-3099(02)00368-712206968 12.MostashariF.FineA.O’LearyD.HuangA.ShermanM.WongS.CampbellG.L.ShiehW.-J.SmithP.GreenbergA.et al.The Outbreak of" exact="West Nile" post="Virus Infection in the New York City Area in"/>
 <result pre="1999N. Engl. J. Med.20013441807181411407341 13.ChanceyC.GrinevA.VolkovaE.RiosM.The Global Ecology and Epidemiology of" exact="West Nile" post="VirusBiomed Res. Int.2015201512010.1155/2015/376230 14.KramerL.D.LiJ.ShiP.Y.West Nile virusLancet. Neurol.2007617118110.1016/S1474-4422(07)70030-317239804 15.KaiserJ.A.BarrettA.D.Twenty Years"/>
 <result pre="Int.2015201512010.1155/2015/376230 14.KramerL.D.LiJ.ShiP.Y.West Nile virusLancet. Neurol.2007617118110.1016/S1474-4422(07)70030-317239804 15.KaiserJ.A.BarrettA.D.Twenty Years of Progress toward" exact="West Nile" post="Virus Vaccine DevelopmentViruses20191182310.3390/v11090823 16.collab: CDCWest Nile VirusAvailable online: https://www.cdc.gov/westnile/healthcareproviders/healthcareproviders-diagnostic.html(accessed"/>
 <result pre="2018) 17.MartinovicV.Kisic-TepavcevicD.KacarA.MesarosS.PekmezovicT.DrulovicJ.Longitudinally extensive transverse myelitis in a patient infected with" exact="West Nile" post="virusMult. Scler. Relat. Disord.201932192210.1016/j.msard.2019.04.00731005826 18.PradhanS.AnandS.ChoudhuryS.S.Cognitive behavioural impairment with irreversible"/>
 <result pre="behavioural impairment with irreversible sensorineural deafness as a complication of" exact="West Nile" post="encephalitisJ. Neurovirol.20192542943310.1007/s13365-019-00733-230903400 19.BurdmannE.A.Flaviviruses and Kidney DiseasesAdv. Chronic Kidney Dis.20192619820610.1053/j.ackd.2019.01.00231202392"/>
 <result pre="encephalitisJ. Neurovirol.20192542943310.1007/s13365-019-00733-230903400 19.BurdmannE.A.Flaviviruses and Kidney DiseasesAdv. Chronic Kidney Dis.20192619820610.1053/j.ackd.2019.01.00231202392 20.ConettaR.TeixeiraA.A.WaldmanG.SampsonB.A.AsnisD.S.The" exact="West Nile" post="Virus Outbreak of 1999 in New York: The Flushing"/>
 <result pre="The Flushing Hospital ExperienceClin. Infect. Dis.20003041341810722421 21.SampsonB.A.AmbrosiC.CharlotA.ReiberK.VeressJ.F.ArmbrustmacherV.The pathology of human" exact="West Nile" post="virus infectionHum. Pathol.20003152753110.1053/hp.2000.804710836291 22.LeisA.A.PolkJ.L.DostrowV.WinkelmannM.StokicD.S.A Poliomyelitis-like Syndrome from West Nile"/>
 <result pre="human West Nile virus infectionHum. Pathol.20003152753110.1053/hp.2000.804710836291 22.LeisA.A.PolkJ.L.DostrowV.WinkelmannM.StokicD.S.A Poliomyelitis-like Syndrome from" exact="West Nile" post="Virus InfectionN. Engl. J. Med.20023471279128010.1056/NEJM2002c02158712270971 23.LiJ.LoebJ.A.ShyM.E.ShahA.K.TselisA.C.KupskiW.J.LewisR.A.Asymmetric flaccid paralysis: A"/>
 <result pre="Engl. J. Med.20023471279128010.1056/NEJM2002c02158712270971 23.LiJ.LoebJ.A.ShyM.E.ShahA.K.TselisA.C.KupskiW.J.LewisR.A.Asymmetric flaccid paralysis: A neuromuscular presentation of" exact="West Nile" post="virus infectionAnn. Neurol.20035370371010.1002/ana.1057512783415 24.JehaL.E.SilaC.A.LedermanR.J.PraysonR.A.IsadaC.M.GordonS.M.West Nile virus infection: A new"/>
 <result pre="virus infection: A new acute paralytic illnessNeurology200361555910.1212/01.WNL.0000073617.08185.0A12847156 25.LeisA.A.StokicD.S.Neuromuscular Manifestations of" exact="West Nile" post="Virus InfectionFront. Neurol.201233710.3389/fneur.2012.0003722461779 26.LeisA.A.StokicD.S.WebbR.M.SlavinskiS.A.FratkinJ.Clinical spectrum of muscle weakness in"/>
 <result pre="Virus InfectionFront. Neurol.201233710.3389/fneur.2012.0003722461779 26.LeisA.A.StokicD.S.WebbR.M.SlavinskiS.A.FratkinJ.Clinical spectrum of muscle weakness in human" exact="West Nile" post="virus infectionMuscle Nerve20032830230810.1002/mus.1044012929189 27.SejvarJ.J.LeisA.A.StokicD.S.Van GerpenJ.A.MarfinA.A.WebbR.HaddadM.B.TierneyB.C.SlavinskiS.A.PolkJ.L.et al.Acute Flaccid Paralysis and"/>
 <result pre="Nile virus infectionMuscle Nerve20032830230810.1002/mus.1044012929189 27.SejvarJ.J.LeisA.A.StokicD.S.Van GerpenJ.A.MarfinA.A.WebbR.HaddadM.B.TierneyB.C.SlavinskiS.A.PolkJ.L.et al.Acute Flaccid Paralysis and" exact="West Nile" post="Virus InfectionEmerg. Infect. Dis.2003978879310.3201/eid0907.03012912890318 28.JohnstoneJ.HannaS.E.NicolleL.E.DrebotM.A.NeupaneB.MahonyJ.B.LoebM.B.Prognosis of West Nile virus"/>
 <result pre="Paralysis and West Nile Virus InfectionEmerg. Infect. Dis.2003978879310.3201/eid0907.03012912890318 28.JohnstoneJ.HannaS.E.NicolleL.E.DrebotM.A.NeupaneB.MahonyJ.B.LoebM.B.Prognosis of" exact="West Nile" post="virus associated acute flaccid paralysis: A case seriesJ. Med."/>
 <result pre="case seriesJ. Med. Case Rep.2011539510.1186/1752-1947-5-39521854567 29.FratkinJ.D.LeisA.A.StokicD.S.SlavinskiS.A.GeissR.W.Spinal cord neuropathology in human" exact="West Nile" post="virus infectionArch. Pathol. Lab. Med.200412853353715086282 30.GarciaM.N.HauseA.M.WalkerC.M.OrangeJ.S.HasbunR.MurrayK.O.Evaluation of Prolonged Fatigue"/>
 <result pre="J.20031681399140512771068 32.LindseyN.P.SejvarJ.J.BodeA.V.PapeW.J.CampbellG.L.Delayed Mortality in a Cohort of Persons Hospitalized with" exact="West Nile" post="Virus Disease in Colorado in 2003Vector Borne Zoonotic Dis.20121223023510.1089/vbz.2011.072122022816"/>
 <result pre="Borne Zoonotic Dis.20121223023510.1089/vbz.2011.072122022816 33.WangH.SiddharthanV.HallJ.O.MorreyJ.D.Autonomic Nervous Dysfunction in Hamsters Infected with" exact="West Nile" post="VirusPLoS ONE20116e1957510.1371/journal.pone.001957521573009 34.MorreyJ.D.SiddharthanV.WangH.HallJ.O.MotterN.E.SkinnerR.D.SkirpstunasR.T.Neurological suppression of diaphragm electromyographs in hamsters"/>
 <result pre="ONE20116e1957510.1371/journal.pone.001957521573009 34.MorreyJ.D.SiddharthanV.WangH.HallJ.O.MotterN.E.SkinnerR.D.SkirpstunasR.T.Neurological suppression of diaphragm electromyographs in hamsters infected with" exact="West Nile" post="virusJ. Neurovirol.20101631832910.3109/13550284.2010.50184720632796 35.ZukorK.WangH.HurstB.L.SiddharthanV.Van WettereA.PilowskyP.M.MorreyJ.D.Phrenic nerve deficits and neurological immunopathology"/>
 <result pre="35.ZukorK.WangH.HurstB.L.SiddharthanV.Van WettereA.PilowskyP.M.MorreyJ.D.Phrenic nerve deficits and neurological immunopathology associated with acute" exact="West Nile" post="virus infection in mice and hamstersJ. Neurovirol.20172318620410.1007/s13365-016-0488-627761801 36.BudhramA.SharmaM.ShettarB.Hosseini-MoghaddamS.M.KhawA.V.Sensory and"/>
 <result pre="in mice and hamstersJ. Neurovirol.20172318620410.1007/s13365-016-0488-627761801 36.BudhramA.SharmaM.ShettarB.Hosseini-MoghaddamS.M.KhawA.V.Sensory and autonomic involvement in" exact="West Nile" post="virus-associated acute flaccid paralysisNeurol. Clin. Pract.2017739439710.1212/CPJ.000000000000037329620087 37.TownT.JengD.AlexopoulouL.TanJ.FlavellR.A.Microglia recognize double-stranded"/>
 <result pre="TLR3J. Immunol.20061763804381210.4049/jimmunol.176.6.380416517751 38.DaffisS.SamuelM.A.SutharM.S.GaleM.DiamondM.S.Toll-Like Receptor 3 Has a Protective Role against" exact="West Nile" post="Virus InfectionJ. Virol.200882103491035810.1128/JVI.00935-0818715906 39.ScholleF.MasonP.W.West Nile virus replication interferes with"/>
 <result pre="transcription and response to interferon treatmentVirology2005342778710.1016/j.virol.2005.07.02116111732 40.WangT.TownT.AlexopoulouL.AndersonJ.F.FikrigE.FlavellR.A.Toll-like receptor 3 mediates" exact="West Nile" post="virus entry into the brain causing lethal encephalitisNat. Med.2004101366137310.1038/nm114015558055"/>
 <result pre="brain causing lethal encephalitisNat. Med.2004101366137310.1038/nm114015558055 41.TownT.BaiF.WangT.KaplanA.T.QianF.MontgomeryR.R.AndersonJ.F.FlavellR.A.FikrigE.Toll-like receptor 7 mitigates lethal" exact="West Nile" post="encephalitis via interleukin 23-dependent immune cell infiltration and homingImmunity20093024225310.1016/j.immuni.2008.11.01219200759"/>
 <result pre="43.PaulA.M.AcharyaD.LeL.WangP.StokicD.S.LeisA.A.AlexopoulouL.TownT.FlavellR.A.FikrigE.et al.TLR8 Couples SOCS-1 and Restrains TLR7-Mediated Antiviral Immunity, Exacerbating" exact="West Nile" post="Virus Infection in MiceJ. Immunol.20161974425443510.4049/jimmunol.160090227798161 44.KatoH.TakeuchiO.Mikamo-SatohE.HiraiR.KawaiT.MatsushitaK.HiiragiA.DermodyT.S.FujitaT.AkiraS.Length-dependent recognition of double-stranded"/>
 <result pre="T cell survival and fitnessImmunity20123723524810.1016/j.immuni.2012.07.00422841161 54.SamuelM.A.DiamondM.S.Alpha/Beta Interferon Protects against Lethal" exact="West Nile" post="Virus Infection by Restricting Cellular Tropism and Enhancing Neuronal"/>
 <result pre="Neuronal SurvivalJ. Virol.200579133501336110.1128/JVI.79.21.13350-13361.200516227257 55.LiuW.J.WangX.J.ClarkD.C.LobigsM.HallR.A.KhromykhA.A.A Single Amino Acid Substitution in the" exact="West Nile" post="Virus Nonstructural Protein NS2A Disables Its Ability To Inhibit"/>
 <result pre="Inhibition of Beta Interferon Promoter-Driven TranscriptionJ. Virol.200478122251223510.1128/JVI.78.22.12225-12235.200415507609 61.SetohY.X.PeriasamyP.PengN.Y.G.AmarillaA.A.SlonchakA.KhromykhA.A.Helicase Domain of" exact="West Nile" post="Virus NS3 Protein Plays a Role in Inhibition of"/>
 <result pre="immune evasionJ. Virol.2011852723273210.1128/JVI.02050-1021191014 63.Laurent-RolleM.BoerE.F.LubickK.J.WolfinbargerJ.B.CarmodyA.B.RockxB.LiuW.AshourJ.ShupertW.L.HolbrookM.R.et al.The NS5 Protein of the Virulent" exact="West Nile" post="Virus NY99 Strain Is a Potent Antagonist of Type"/>
 <result pre="SignalingJ. Virol.2010843503351510.1128/JVI.01161-0920106931 64.Chan-TackK.M.ForrestG.Failure of interferon alpha-2b in a patient with" exact="West Nile" post="virus meningoencephalitis and acute flaccid paralysisScand. J. Infect. Dis.20053794494610.1080/0036554050026269016308241"/>
 <result pre="differentiation from migrating Ly6C(lo) bone marrow monocytes in early dermal" exact="West Nile" post="virus infectionJ. Immunol.20111862382239610.4049/jimmunol.100268221248254 66.KovatsS.TurnerS.SimmonsA.PoweT.ChakravartyE.Alberola-IlaJ.West Nile virus-infected human dendritic cells"/>
 <result pre="in Dendritic Cells From Older Donors Infected In Vitro With" exact="West Nile" post="VirusJ. Infect. Dis.20112031415142410.1093/infdis/jir04821398396 68.MartinaB.E.KorakaP.van den DoelP.RimmelzwaanG.F.HaagmansB.L.OsterhausA.D.DC-SIGN enhances infection of"/>
 <result pre="Dis.20112031415142410.1093/infdis/jir04821398396 68.MartinaB.E.KorakaP.van den DoelP.RimmelzwaanG.F.HaagmansB.L.OsterhausA.D.DC-SIGN enhances infection of cells with glycosylated" exact="West Nile" post="virus in vitro and virus replication in human dendritic"/>
 <result pre="69.SilvaM.C.Guerrero-PlataA.GilfoyF.D.GarofaloR.P.MasonP.W.Differential Activation of Human Monocyte-Derived and Plasmacytoid Dendritic Cells by" exact="West Nile" post="Virus Generated in Different Host CellsJ. Virol.200781136401364810.1128/JVI.00857-0717913823 70.SchmidE.T.PangI.K.SilvaE.A.C.BosurgiL.MinerJ.J.DiamondM.S.IwasakiA.RothlinC.V.AXL receptor"/>
 <result pre="72.ChowK.T.DriscollC.LooY.M.KnollM.GaleM.Jr.IRF5 regulates unique subset of genes in dendritic cells during" exact="West Nile" post="virus infectionJ. Leukoc. Biol.201910541142510.1002/JLB.MA0318-136RRR30457675 73.LazearH.M.LancasterA.WilkinsC.SutharM.S.HuangA.VickS.C.ClepperL.ThackrayL.BrassilM.M.VirginH.W.et al.IRF-3, IRF-5, and IRF-7"/>
 <result pre="Virol.199614145946910.1007/BF017183108645088 75.LuoH.WinkelmannE.R.ZhuS.RuW.MaysE.SilvasJ.A.VollmerL.L.GaoJ.PengB.-H.BoppN.E.et al.Peli1 facilitates virus replication and promotes neuroinflammation during" exact="West Nile" post="virus infectionJ. Clin. Investig.20181284980499110.1172/JCI9990230247157 76.DrescherB.BaiF.Neutrophil in viral infections, friend"/>
 <result pre="Res.20131711710.1016/j.virusres.2012.11.00223178588 77.BaiF.KongK.DaiJ.QianF.ZhangL.BrownC.R.FikrigE.MontgometryR.R.A Paradoxical Role for Neutrophils in the Pathogenesis of" exact="West Nile" post="VirusJ. Infect. Dis.20102021804181210.1086/65741621050124 78.PaulA.M.AcharyaD.DutyL.ThompsonE.A.LeL.StokicD.S.LeisA.A.BaiF.Osteopontin facilitates West Nile virus neuroinvasion"/>
 <result pre="the Pathogenesis of West Nile VirusJ. Infect. Dis.20102021804181210.1086/65741621050124 78.PaulA.M.AcharyaD.DutyL.ThompsonE.A.LeL.StokicD.S.LeisA.A.BaiF.Osteopontin facilitates" exact="West Nile" post="virus neuroinvasion via neutrophil &quot;Trojan horse�? transportSci. Rep.20177472210.1038/s41598-017-04839-728680095 79.WangP.BaiF.ZenewiczL.A.DaiJ.GateD.ChengG.YangL.QianF.YuanX.MontgomeryR.R.et"/>
 <result pre="neutrophil &quot;Trojan horse�? transportSci. Rep.20177472210.1038/s41598-017-04839-728680095 79.WangP.BaiF.ZenewiczL.A.DaiJ.GateD.ChengG.YangL.QianF.YuanX.MontgomeryR.R.et al.IL-22 Signaling Contributes to" exact="West Nile" post="Encephalitis PathogenesisPLoS ONE20127e4415310.1371/journal.pone.004415322952908 80.VivierE.TomaselloE.BaratinM.WalzerT.UgoliniS.Functions of natural killer cellsNat. Immunol.2008950351010.1038/ni158218425107"/>
 <result pre="killer cellsJ. Neuroimmunol.19881910111010.1016/0165-5728(88)90039-23397404 82.ShresthaB.SamuelM.A.DiamondM.S.CD8+ T cells require perforin to clear" exact="West Nile" post="virus from infected neuronsJ. Virol.20068011912910.1128/JVI.80.1.119-129.200616352536 83.ZhangM.DanielS.HuangY.ChanceyC.HuangQ.LeiY.F.GrinevA.MostowskiH.RiosM.DaytonA.Anti-West Nile virus activity"/>
 <result pre="natural killer cellsBMC Immunol.201011310.1186/1471-2172-11-320089143 84.YaoY.Strauss-AlbeeD.M.ZhouJ.Q.MalawistaA.GarciaM.N.MurrayK.O.BlishC.A.MontgomeryR.R.The natural killer cell response to" exact="West Nile" post="virus in young and old individuals with or without"/>
 <result pre="Interferon Plays a Crucial Early Antiviral Role in Protection against" exact="West Nile" post="Virus InfectionJ. Virol.2006805338534810.1128/JVI.00274-0616699014 86.WangT.ScullyE.YinZ.KimJ.H.WangS.YanJ.MamulaM.AndersonJ.F.CraftJ.FikrigE.IFN-gamma-producing gamma delta T cells help"/>
 <result pre="InfectionJ. Virol.2006805338534810.1128/JVI.00274-0616699014 86.WangT.ScullyE.YinZ.KimJ.H.WangS.YanJ.MamulaM.AndersonJ.F.CraftJ.FikrigE.IFN-gamma-producing gamma delta T cells help control murine" exact="West Nile" post="virus infectionJ. Immunol.20031712524253110.4049/jimmunol.171.5.252412928402 87.WelteT.LambJ.AndersonJ.F.BornW.K.O’BrienR.L.WangT.Role of two distinct gammadelta T"/>
 <result pre="Immunol.20031712524253110.4049/jimmunol.171.5.252412928402 87.WelteT.LambJ.AndersonJ.F.BornW.K.O’BrienR.L.WangT.Role of two distinct gammadelta T cell subsets during" exact="West Nile" post="virus infectionFEMS Immunol. Med. Microbiol.20085327528310.1111/j.1574-695X.2008.00430.x18513355 88.BaiF.TownT.QianF.WangP.KamanakaM.ConnollyT.M.GateD.MontgomeryR.R.FlavellR.A.FikrigE.IL-10 Signaling Blockade Controls"/>
 <result pre="virus infectionFEMS Immunol. Med. Microbiol.20085327528310.1111/j.1574-695X.2008.00430.x18513355 88.BaiF.TownT.QianF.WangP.KamanakaM.ConnollyT.M.GateD.MontgomeryR.R.FlavellR.A.FikrigE.IL-10 Signaling Blockade Controls Murine" exact="West Nile" post="Virus InfectionPLoS Pathog.20095e100061010.1371/journal.ppat.100061019816558 89.WelteT.AronsonJ.GongB.RachamalluA.MendellN.TeshR.PaesslerS.BornW.K.O’BrienR.L.WangT.Vgamma4+ T cells regulate host immune"/>
 <result pre="InfectionPLoS Pathog.20095e100061010.1371/journal.ppat.100061019816558 89.WelteT.AronsonJ.GongB.RachamalluA.MendellN.TeshR.PaesslerS.BornW.K.O’BrienR.L.WangT.Vgamma4+ T cells regulate host immune response to" exact="West Nile" post="virus infectionFEMS Immunol. Med. Microbiol.20116318319210.1111/j.1574-695X.2011.00840.x22077221 90.MehlhopE.WhitbyK.OliphantT.MarriA.EngleM.DiamondM.S.Complement Activation Is Required"/>
 <result pre="Is Required for Induction of a Protective Antibody Response against" exact="West Nile" post="Virus InfectionJ. Virol.2005797466747710.1128/JVI.79.12.7466-7477.200515919902 91.MehlhopE.DiamondM.S.Protective immune responses against West Nile"/>
 <result pre="against West Nile Virus InfectionJ. Virol.2005797466747710.1128/JVI.79.12.7466-7477.200515919902 91.MehlhopE.DiamondM.S.Protective immune responses against" exact="West Nile" post="virus are primed by distinct complement activation pathwaysJ. Exp."/>
 <result pre="protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of" exact="West Nile" post="virusCell Host Microbe2009638139110.1016/j.chom.2009.09.00319837377 97.FuchsA.PintoA.K.SchwaebleW.J.DiamondM.S.The lectin pathway of complement activation"/>
 <result pre="97.FuchsA.PintoA.K.SchwaebleW.J.DiamondM.S.The lectin pathway of complement activation contributes to protection from" exact="West Nile" post="virus infectionVirology201141210110910.1016/j.virol.2011.01.00321269656 98.MehlhopE.FuchsA.EngleM.DiamondM.S.Complement modulates pathogenesis and antibody-dependent neutralization of"/>
 <result pre="Nile virus infectionVirology201141210110910.1016/j.virol.2011.01.00321269656 98.MehlhopE.FuchsA.EngleM.DiamondM.S.Complement modulates pathogenesis and antibody-dependent neutralization of" exact="West Nile" post="virus infection through a C5-independent mechanismVirology2009393111510.1016/j.virol.2009.08.01919744691 99.DiamondM.S.ShresthaB.MarriA.MahanD.EngleM.B Cells and"/>
 <result pre="Critical Roles in the Immediate Defense of Disseminated Infection by" exact="West Nile" post="Encephalitis VirusJ. Virol.2003772578258610.1128/JVI.77.4.2578-2586.200312551996 100.EngleM.J.DiamondM.S.Antibody Prophylaxis and Therapy against West"/>
 <result pre="West Nile Encephalitis VirusJ. Virol.2003772578258610.1128/JVI.77.4.2578-2586.200312551996 100.EngleM.J.DiamondM.S.Antibody Prophylaxis and Therapy against" exact="West Nile" post="Virus Infection in Wild-Type and Immunodeficient MiceJ. Virol.200377129411294910.1128/JVI.77.24.12941-12949.200314645550 101.DiamondM.S.SitatiE.M.FriendL.D.HiggsS.ShresthaB.EngleM.A"/>
 <result pre="101.DiamondM.S.SitatiE.M.FriendL.D.HiggsS.ShresthaB.EngleM.A Critical Role for Induced IgM in the Protection against" exact="West Nile" post="Virus InfectionJ. Exp. Med.20031981853186210.1084/jem.2003122314662909 102.XiaJ.WinkelmannE.R.GorderS.R.MasonP.W.MilliganG.N.TLR3- and MyD88-Dependent Signaling Differentially"/>
 <result pre="Med.20031981853186210.1084/jem.2003122314662909 102.XiaJ.WinkelmannE.R.GorderS.R.MasonP.W.MilliganG.N.TLR3- and MyD88-Dependent Signaling Differentially Influences the Development of" exact="West Nile" post="Virus-Specific B Cell Responses in Mice following Immunization with"/>
 <result pre="a Single-Cycle Flavivirus Vaccine CandidateJ. Virol.201387120901210110.1128/JVI.01469-1323986602 103.PurthaW.E.ChachuK.A.VirginH.W.DiamondM.S.Early B-Cell Activation after" exact="West Nile" post="Virus Infection Requires Alpha/Beta Interferon but Not Antigen Receptor"/>
 <result pre="Not Antigen Receptor SignalingJ. Virol.200882109641097410.1128/JVI.01646-0818786989 104.GormanM.J.PoddarS.FarzanM.DiamondM.S.The Interferon-Stimulated Gene Ifitm3 Restricts" exact="West Nile" post="Virus Infection and PathogenesisJ. Virol.2016908212822510.1128/JVI.00581-1627384652 105.ThackrayL.B.ShresthaB.RichnerJ.M.MinerJ.J.PintoA.K.LaZearH.M.GaleM.DiamondM.S.Interferon Regulatory Factor 5-Dependent"/>
 <result pre="5-Dependent Immune Responses in the Draining Lymph Node Protect against" exact="West Nile" post="Virus InfectionJ. Virol.201488110071102110.1128/JVI.01545-1425031348 106.GiordanoD.DravesK.E.YoungL.B.RoeK.BryanM.A.DreschC.RichnerJ.M.DiamondM.S.GaleM.ClarkE.A.Protection of mice deficient in mature"/>
 <result pre="Virol.201488110071102110.1128/JVI.01545-1425031348 106.GiordanoD.DravesK.E.YoungL.B.RoeK.BryanM.A.DreschC.RichnerJ.M.DiamondM.S.GaleM.ClarkE.A.Protection of mice deficient in mature B cells from" exact="West Nile" post="virus infection by passive and active immunizationPLoS Pathog.201713e100674310.1371/journal.ppat.100674329176765 107.MehlhopE.Ansarah-SobrinhoC.JohnsonS.EngleM.FremontD.H.PiersonT.C.DiamondM.S.Complement"/>
 <result pre="mannerCell Host Microbe2007241742610.1016/j.chom.2007.09.01518078693 108.RoeK.GiordanoD.YoungL.B.DravesK.E.HolderU.SutharM.S.GaleM.ClarkE.A.Dendritic cell-associated MAVS is required to control" exact="West Nile" post="virus replication and ensuing humoral immune responsesPLoS ONE201914e021892810.1371/journal.pone.021892831242236 109.SitatiE.McCandlessE.E.KleinR.S.DiamondM.S.CD40-CD40"/>
 <result pre="of CD8+ T cells into the brain and protection against" exact="West Nile" post="virus encephalitisJ. Virol.2007819801981110.1128/JVI.00941-0717626103 110.SitatiE.M.DiamondM.S.CD4+ T-cell responses are required for"/>
 <result pre="encephalitisJ. Virol.2007819801981110.1128/JVI.00941-0717626103 110.SitatiE.M.DiamondM.S.CD4+ T-cell responses are required for clearance of" exact="West Nile" post="virus from the central nervous systemJ. Virol.200680120601206910.1128/JVI.01650-0617035323 111.ShresthaB.DiamondM.S.Role of"/>
 <result pre="systemJ. Virol.200680120601206910.1128/JVI.01650-0617035323 111.ShresthaB.DiamondM.S.Role of CD8+ T cells in control of" exact="West Nile" post="virus infectionJ. Virol.2004788312832110.1128/JVI.78.15.8312-8321.200415254203 112.ShresthaB.DiamondM.S.Fas ligand interactions contribute to CD8+"/>
 <result pre="Virol.2004788312832110.1128/JVI.78.15.8312-8321.200415254203 112.ShresthaB.DiamondM.S.Fas ligand interactions contribute to CD8+ T-cell-mediated control of" exact="West Nile" post="virus infection in the central nervous systemJ. Virol.200781117491175710.1128/JVI.01136-0717804505 113.ShresthaB.PintoA.K.GreenS.BoschI.DiamondM.S.CD8+"/>
 <result pre="nervous systemJ. Virol.200781117491175710.1128/JVI.01136-0717804505 113.ShresthaB.PintoA.K.GreenS.BoschI.DiamondM.S.CD8+ T cells use TRAIL to restrict" exact="West Nile" post="virus pathogenesis by controlling infection in neuronsJ. Virol.2012868937894810.1128/JVI.00673-1222740407 114.KleinR.S.LinE.ZhangB.LusterA.D.TollettJ.SamuelM.A.EngleM.DiamondM.S.Neuronal"/>
 <result pre="Virol.2012868937894810.1128/JVI.00673-1222740407 114.KleinR.S.LinE.ZhangB.LusterA.D.TollettJ.SamuelM.A.EngleM.DiamondM.S.Neuronal CXCL10 directs CD8+ T-cell recruitment and control of" exact="West Nile" post="virus encephalitisJ. Virol.200579114571146610.1128/JVI.79.17.11457-11466.200516103196 115.ZhangB.ChanY.K.LuB.DiamondM.S.KleinR.S.CXCR3 mediates region-specific antiviral T cell"/>
 <result pre="antiviral T cell trafficking within the central nervous system during" exact="West Nile" post="virus encephalitisJ. Immunol.20081802641264910.4049/jimmunol.180.4.264118250476 116.McCandlessE.E.WangQ.WoernerB.M.HarperJ.M.KleinR.S.CXCL12 limits inflammation by localizing mononuclear"/>
 <result pre="trafficking in the central nervous system and improves survival from" exact="West Nile" post="virus encephalitisProc. Natl. Acad. Sci. USA2008105112701127510.1073/pnas.080089810518678898 118.AcharyaD.WangP.PaulA.M.DaiJ.GateD.LoweryJ.E.StokicD.S.LeisA.A.FlavellR.A.TownT.et al.Interleukin-17A Promotes"/>
 <result pre="USA2008105112701127510.1073/pnas.080089810518678898 118.AcharyaD.WangP.PaulA.M.DaiJ.GateD.LoweryJ.E.StokicD.S.LeisA.A.FlavellR.A.TownT.et al.Interleukin-17A Promotes CD8+ T Cell Cytotoxicity To Facilitate" exact="West Nile" post="Virus ClearanceJ. Virol.201791e01529-1610.1128/JVI.01529-1627795421 119.WangY.LobigsM.LeeE.MullbacherA.CD8+ T cells mediate recovery and"/>
 <result pre="ClearanceJ. Virol.201791e01529-1610.1128/JVI.01529-1627795421 119.WangY.LobigsM.LeeE.MullbacherA.CD8+ T cells mediate recovery and immunopathology in" exact="West Nile" post="virus encephalitisJ. Virol.200377133231333410.1128/JVI.77.24.13323-13334.200314645588 120.SzretterK.J.DanielsB.P.ChoH.GaineyM.D.YokoyamaW.M.GaleM.VirginH.W.KleinR.S.SenG.C.DiamondM.S.2′-O Methylation of the Viral mRNA"/>
 <result pre="encephalitisJ. Virol.200377133231333410.1128/JVI.77.24.13323-13334.200314645588 120.SzretterK.J.DanielsB.P.ChoH.GaineyM.D.YokoyamaW.M.GaleM.VirginH.W.KleinR.S.SenG.C.DiamondM.S.2′-O Methylation of the Viral mRNA Cap by" exact="West Nile" post="Virus Evades Ifit1-Dependent and -Independent Mechanisms of Host Restriction"/>
 <result pre="for dendritic cell–mediated T cell reactivation within the CNS during" exact="West Nile" post="virus encephalitisJ. Exp. Med.201321050351610.1084/jem.2012189723460727 123.ShresthaB.NgT.ChuH.J.NollM.DiamondM.S.The relative contribution of antibody"/>
 <result pre="of antibody and CD8+ T cells to vaccine immunity against" exact="West Nile" post="encephalitis virusVaccine2008262020203310.1016/j.vaccine.2008.02.00918339459 124.LanteriM.C.O’BrienK.M.PurthaW.E.CameronM.J.LundJ.M.OwenR.E.HeitmanJ.W.CusterB.HirschkornD.F.ToblerL.H.et al.Tregs control the development of symptomatic"/>
 <result pre="Nile encephalitis virusVaccine2008262020203310.1016/j.vaccine.2008.02.00918339459 124.LanteriM.C.O’BrienK.M.PurthaW.E.CameronM.J.LundJ.M.OwenR.E.HeitmanJ.W.CusterB.HirschkornD.F.ToblerL.H.et al.Tregs control the development of symptomatic" exact="West Nile" post="virus infection in humans and miceJ. Clin. Investig.20091193266327710.1172/JCI3938719855131 125.GrahamJ.B.Da"/>
 <result pre="Adaptive T Cell Responses and Host Resistance to an Attenuated" exact="West Nile" post="Virus Infection in Old MiceJ. Virol.2016901333134410.1128/JVI.02488-1526581984 128.ShresthaB.GottliebD.DiamondM.S.Infection and Injury"/>
 <result pre="in Old MiceJ. Virol.2016901333134410.1128/JVI.02488-1526581984 128.ShresthaB.GottliebD.DiamondM.S.Infection and Injury of Neurons by" exact="West Nile" post="Encephalitis VirusJ. Virol.200377132031321310.1128/JVI.77.24.13203-13213.200314645577 129.PhilpottD.C.E.NolanM.S.EvertN.MayesB.HesalroadD.FonkenE.MurrayK.O.Acute and Delayed Deaths after West"/>
 <result pre="West Nile Encephalitis VirusJ. Virol.200377132031321310.1128/JVI.77.24.13203-13213.200314645577 129.PhilpottD.C.E.NolanM.S.EvertN.MayesB.HesalroadD.FonkenE.MurrayK.O.Acute and Delayed Deaths after" exact="West Nile" post="Virus Infection, Texas, USA, 2002–2012Emerg. Infect. Dis.20192510.3201/eid2502.181250 130.DiamondM.S.KleinR.S.West Nile"/>
 <result pre="the blood-brain barrierNat. Med.2004101294129510.1038/nm1204-129415580248 131.DaiJ.WangP.BaiF.TownT.FikrigE.ICAM-1 participates in the entry of" exact="West Nile" post="virus into the central nervous systemJ. Virol.2008824164416810.1128/JVI.02621-0718256150 132.WangP.DaiJ.BaiF.KongK.-F.WongS.J.MontgomeryR.R.MadriJ.A.FikrigE.Matrix Metalloproteinase"/>
 <result pre="into the central nervous systemJ. Virol.2008824164416810.1128/JVI.02621-0718256150 132.WangP.DaiJ.BaiF.KongK.-F.WongS.J.MontgomeryR.R.MadriJ.A.FikrigE.Matrix Metalloproteinase 9 Facilitates" exact="West Nile" post="Virus Entry into the BrainJ. Virol.2008828978898510.1128/JVI.00314-0818632868 133.ArjonaA.FoellmerH.G.TownT.LengL.McDonaldC.WangT.WongS.J.MontgomeryR.R.FikrigE.BucalaR.Abrogation of macrophage"/>
 <result pre="the BrainJ. Virol.2008828978898510.1128/JVI.00314-0818632868 133.ArjonaA.FoellmerH.G.TownT.LengL.McDonaldC.WangT.WongS.J.MontgomeryR.R.FikrigE.BucalaR.Abrogation of macrophage migration inhibitory factor decreases" exact="West Nile" post="virus lethality by limiting viral neuroinvasionJ. Clin. Investig.20071173059306610.1172/JCI3221817909632 134.SchäferA.BrookeC.B.WhitmoreA.C.JohnstonR.E.The"/>
 <result pre="Equine Encephalitis Virus InfectionJ. Virol.201185106821069010.1128/JVI.05032-1121849461 135.BrownA.N.KentK.A.BennettC.J.BernardK.A.Tissue tropism and neuroinvasion of" exact="West Nile" post="virus do not differ for two mouse strains with"/>
 <result pre="targeting the west nile virus envelope proteinJ. Virol.2007812047205510.1128/JVI.01840-0617151121 138.SuenW.W.ProwN.A.HallR.A.Bielefeldt-OhmannH.Mechanism of" exact="West Nile" post="Virus Neuroinvasion: A Critical AppraisalViruses201462796282510.3390/v607279625046180 139.CantileC.Del PieroF.Di GuardoG.ArispiciM.Pathologic and"/>
 <result pre="AppraisalViruses201462796282510.3390/v607279625046180 139.CantileC.Del PieroF.Di GuardoG.ArispiciM.Pathologic and immunohistochemical findings in naturally occuring" exact="West Nile" post="virus infection in horsesVet. Pathol.20013841443110.1354/vp.38-4-41411467475 140.GuarnerJ.ShiehW.-J.HunterS.PaddockC.D.MorkenT.CampbellG.L.MarfinA.A.ZakiS.R.Clinicopathologic study and laboratory"/>
 <result pre="Pathol.20013841443110.1354/vp.38-4-41411467475 140.GuarnerJ.ShiehW.-J.HunterS.PaddockC.D.MorkenT.CampbellG.L.MarfinA.A.ZakiS.R.Clinicopathologic study and laboratory diagnosis of 23 cases with" exact="West Nile" post="virus encephalomyelitisHum. Pathol.20043598399010.1016/j.humpath.2004.04.00815297965 141.WangS.WelteT.McGargillM.TownT.ThompsonJ.AndersonJ.F.FlavellR.A.FikrigE.HedrickS.M.WangT.Drak2 contributes to West Nile virus"/>
 <result pre="cases with West Nile virus encephalomyelitisHum. Pathol.20043598399010.1016/j.humpath.2004.04.00815297965 141.WangS.WelteT.McGargillM.TownT.ThompsonJ.AndersonJ.F.FlavellR.A.FikrigE.HedrickS.M.WangT.Drak2 contributes to" exact="West Nile" post="virus entry into the brain and lethal encephalitisJ. Immunol.20081812084209110.4049/jimmunol.181.3.208418641347"/>
 <result pre="mediates enhanced flavivirus replication in macrophagesJ. Exp. Med.198315825826310.1084/jem.158.1.2586864163 143.SamuelM.A.DiamondM.S.Pathogenesis of" exact="West Nile" post="Virus Infection: A Balance between Virulence, Innate and Adaptive"/>
 <result pre="and Viral EvasionJ. Virol.2006809349936010.1128/JVI.01122-0616973541 144.BrehinA.C.MouriesJ.FrenkielM.P.DadaglioG.DespresP.LafonM.CoudercT.Dynamics of immune cell recruitment during" exact="West Nile" post="encephalitis and identification of a new CD19+B220-BST-2+ leukocyte populationJ."/>
 <result pre="CD19+B220-BST-2+ leukocyte populationJ. Immunol.20081806760676710.4049/jimmunol.180.10.676018453596 145.RawalA.GavinP.J.SturgisC.D.Cerebrospinal fluid cytology in seasonal epidemic" exact="West Nile" post="virus meningo-encephalitisDiagn. Cytopathol.20063412712910.1002/dc.2041016511849 146.TylerK.L.PapeJ.GoodyR.J.CorkillM.Kleinschmidt-DeMastersB.K.CSF findings in 250 patients with"/>
 <result pre="meningo-encephalitisDiagn. Cytopathol.20063412712910.1002/dc.2041016511849 146.TylerK.L.PapeJ.GoodyR.J.CorkillM.Kleinschmidt-DeMastersB.K.CSF findings in 250 patients with serologically confirmed" exact="West Nile" post="virus meningitis and encephalitisNeurology20066636136510.1212/01.wnl.0000195890.70898.1f16382032 147.YangJ.-S.RamanathanM.P.MuthumaniK.ChooA.Y.JinS.-H.YuQ.-C.HwangD.S.ChooD.K.LeeM.D.DangK.et al.Induction of Inflammation by"/>
 <result pre="Nile virus meningitis and encephalitisNeurology20066636136510.1212/01.wnl.0000195890.70898.1f16382032 147.YangJ.-S.RamanathanM.P.MuthumaniK.ChooA.Y.JinS.-H.YuQ.-C.HwangD.S.ChooD.K.LeeM.D.DangK.et al.Induction of Inflammation by" exact="West Nile" post="virus Capsid through the Caspase-9 Apoptotic PathwayEmerg. Infect. Dis.200281379138410.3201/eid0812.02022412498651"/>
 <result pre="bax-dependent apoptosisFEBS Lett.2001500172410.1016/S0014-5793(01)02573-X11434919 149.CheeranM.C.-J.HuS.ShengW.S.RashidA.PetersonP.K.LokensgardJ.R.Differential responses of human brain cells to" exact="West Nile" post="virus infectionJ. Neurovirol.20051151252410.1080/1355028050038498216338745 150.QuickE.D.LeserJ.S.ClarkeP.TylerK.L.Activation of Intrinsic Immune Responses and"/>
 <result pre="in an Ex Vivo Spinal Cord Slice Culture Model of" exact="West Nile" post="Virus InfectionJ. Virol.201488130051301410.1128/JVI.01994-1425165111 151.GlassW.G.LimJ.K.CholeraR.PletnevA.G.GaoJ.-L.MurphyP.M.Chemokine receptor CCR5 promotes leukocyte trafficking"/>
 <result pre="CCR5 promotes leukocyte trafficking to the brain and survival in" exact="West Nile" post="virus infectionJ. Exp. Med.20052021087109810.1084/jem.2004253016230476 152.VigP.J.S.LuD.PaulA.M.KuwarR.LopezM.StokicD.S.LeisA.A.GarrettM.R.BaiF.Differential Expression of Genes Related"/>
 <result pre="Ex Vivo Spinal Cord and Cerebellar Slice Cultures Infected with" exact="West Nile" post="VirusBrain Sci.20189110.3390/brainsci901000130586874 153.ArmahH.B.WangG.OmaluB.I.TeshR.B.GyureK.A.ChuteD.J.SmithR.D.DulaiP.VintersH.V.Kleinschmidt-DeMastersB.K.et al.Systemic Distribution of West Nile Virus"/>
 <result pre="Infected with West Nile VirusBrain Sci.20189110.3390/brainsci901000130586874 153.ArmahH.B.WangG.OmaluB.I.TeshR.B.GyureK.A.ChuteD.J.SmithR.D.DulaiP.VintersH.V.Kleinschmidt-DeMastersB.K.et al.Systemic Distribution of" exact="West Nile" post="Virus Infection: Postmortem Immunohistochemical Study of Six CasesBrain Pathol.20071735436210.1111/j.1750-3639.2007.00080.x17610522"/>
 <result pre="155.PetzoldA.GrovesM.LeisA.ScaravilliF.StokicD.StokicD.Neuronal and glial cerebrospinal fluid protein biomarkers are elevated after" exact="West Nile" post="Virus infectionMuscle Nerve201041424910.1002/mus.2144819790244 156.KuwarR.StokicD.LeisA.BaiF.PaulA.FratkinJ.VigP.PaulA.Does astroglial protein S100B contribute to"/>
 <result pre="Nile Virus infectionMuscle Nerve201041424910.1002/mus.2144819790244 156.KuwarR.StokicD.LeisA.BaiF.PaulA.FratkinJ.VigP.PaulA.Does astroglial protein S100B contribute to" exact="West Nile" post="neuro-invasive syndrome?J. Neurol. Sci.201535824325210.1016/j.jns.2015.09.00326382833 157.ChuJ.J.H.NgM.L.The mechanism of cell death"/>
 <result pre="neuro-invasive syndrome?J. Neurol. Sci.201535824325210.1016/j.jns.2015.09.00326382833 157.ChuJ.J.H.NgM.L.The mechanism of cell death during" exact="West Nile" post="virus infection is dependent on initial infectious doseJ. Gen."/>
 <result pre="glycation end-products in neurodegenerative diseasesRev. Neurosci.20152669169810.1515/revneuro-2015-000326226128 160.KumarM.VermaS.NerurkarV.R.Pro-inflammatory cytokines derived from" exact="West Nile" post="virus (WNV)-infected SK-N-SH cells mediate neuroinflammatory markers and neuronal"/>
 <result pre="and neuronal deathJ. Neuroinflamm.201077310.1186/1742-2094-7-73 161.VermaS.KumarM.NerurkarV.R.Cyclooxygenase-2 inhibitor blocks the production of" exact="West Nile" post="virus-induced neuroinflammatory markers in astrocytesJ. Gen. Virol.20119250751510.1099/vir.0.026716-021106803 162.MurrayK.O.GarciaM.N.RahbarM.H.MartínezD.KhuwajaS.A.ArafatR.R.RossmannS.Survival Analysis,"/>
 <result pre="of Recovery up to 8 Years Post-Infection among the Houston" exact="West Nile" post="Virus CohortPLoS ONE20149e10295310.1371/journal.pone.010295325054656 163.WeatherheadJ.E.MillerV.E.GarciaM.N.HasbunR.SalazarL.DimachkieM.M.MurrayK.O.Long-term neurological outcomes in West Nile"/>
 <result pre="Houston West Nile Virus CohortPLoS ONE20149e10295310.1371/journal.pone.010295325054656 163.WeatherheadJ.E.MillerV.E.GarciaM.N.HasbunR.SalazarL.DimachkieM.M.MurrayK.O.Long-term neurological outcomes in" exact="West Nile" post="virus-infected patients: An observational studyAm. J. Trop. Med. Hyg.2015921006101210.4269/ajtmh.14-061625802426"/>
 <result pre="J. Trop. Med. Hyg.2015921006101210.4269/ajtmh.14-061625802426 164.MurrayK.O.NolanM.S.RoncaS.E.DattaS.GovindarajanK.NarayanaP.A.SalazarL.WoodsS.P.HasbunR.The Neurocognitive and MRI Outcomes of" exact="West Nile" post="Virus Infection: Preliminary Analysis Using an External Control GroupFront."/>
 <result pre="myasthenia gravisEur. J. Immunol.2015451339134710.1002/eji.20144506425676041 171.AhmedS.LibmanR.WessonK.AhmedF.EinbergK.Guillain-Barre syndrome: An unusual presentation of" exact="West Nile" post="virus infectionNeurology20005514414610.1212/WNL.55.1.14410891928 172.AlmhannaK.PalanichamyN.SharmaM.HobbsR.SilA.Unilateral Brachial Plexopathy Associated with West Nile"/>
 <result pre="of West Nile virus infectionNeurology20005514414610.1212/WNL.55.1.14410891928 172.AlmhannaK.PalanichamyN.SharmaM.HobbsR.SilA.Unilateral Brachial Plexopathy Associated with" exact="West Nile" post="Virus MeningoencephalitisClin. Infect. Dis.2003361629163010.1086/37523112802774 173.Hassin-BaerS.KirsonE.D.ShulmanL.BuchmanA.S.BinH.HindiyehM.MarkevichL.MendelsonE.Stiff-Person Syndrome Following West Nile"/>
 <result pre="with West Nile Virus MeningoencephalitisClin. Infect. Dis.2003361629163010.1086/37523112802774 173.Hassin-BaerS.KirsonE.D.ShulmanL.BuchmanA.S.BinH.HindiyehM.MarkevichL.MendelsonE.Stiff-Person Syndrome Following" exact="West Nile" post="FeverArch. Neurol.20046193894110.1001/archneur.61.6.93815210535 174.KaragianniP.AlexopoulosH.SourdiA.PapadimitriouD.DimitrakopoulosA.MoutsopoulosH.West Nile Virus infection triggering autoimmune encephalitis:"/>
 <result pre="steroids in the management of acute flaccid paralysis due to" exact="West Nile" post="virus infectionScand. J. Infect. Dis.20043650951210.1080/0036554041002065915307586 178.LeisA.A.SinclairD.J.Lazarus Effect of High"/>
 <result pre="178.LeisA.A.SinclairD.J.Lazarus Effect of High Dose Corticosteroids in a Patient with" exact="West Nile" post="Virus Encephalitis: A Coincidence or a Clue?Front. Med.201968110.3389/fmed.2019.00081 179.HuangC.SlaterB.RuddR.ParchuriN.HullR.DupuisM.HindenburgA.First"/>
 <result pre="Encephalitis: A Coincidence or a Clue?Front. Med.201968110.3389/fmed.2019.00081 179.HuangC.SlaterB.RuddR.ParchuriN.HullR.DupuisM.HindenburgA.First Isolation of" exact="West Nile" post="virus from a Patient with Encephalitis in the United"/>
 <result pre="corticosteroid in the treatment of dengue—A systemic reviewHeliyon20184e0081610.1016/j.heliyon.2018.e0081630258999 Figure 1" exact="West Nile" post="virus (WNV) neuroinvasion and neuropathogenesis."/>
</results>
